• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Magyar Telekom

Magyar Telekom

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

    CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands

  2. Fitch Rates Maine Turnpike Auth Rev Rfdg Bonds 'AA-' & Special Oblig. Bonds 'A-'; Outlook Stable

    Fitch Rates Maine Turnpike Auth Rev Rfdg Bonds 'AA-' & Special Oblig. Bonds 'A-'; Outlook Stable

  3. CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis

    CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of Pacritinib for Patients with Myelofibrosis

  4. IMF Says Growth in Eastern Europe will be Marginal in 2011

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.